Status:
RECRUITING
Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism Pain
Lead Sponsor:
University of Baghdad
Conditions:
Orofacial Pain
Bruxism
Eligibility:
All Genders
15+ years
Phase:
PHASE4
Brief Summary
To evaluate the clinical effectiveness of chlorzoxazone in comparison to orphenadrine Citrate in relieving the orofacial pain in bruxers. Subjects and Methods: 60 patients above 15-years old complaini...
Eligibility Criteria
Inclusion Criteria:
- Patients aged above 15 years-old complaining of orofacial and temporomandibular disorder/pain.
- Patients with no history of chronic systemic illness.
Exclusion Criteria:
- Patients with orofacial injuries.
- Patients with head injuries.
- Patients Taking analgesics for the last 14 days.
Key Trial Info
Start Date :
July 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07109882
Start Date
July 22 2025
End Date
August 30 2025
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Dentistry
Baghdad, Iraq